DE69919863D1 - Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels - Google Patents

Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels

Info

Publication number
DE69919863D1
DE69919863D1 DE69919863T DE69919863T DE69919863D1 DE 69919863 D1 DE69919863 D1 DE 69919863D1 DE 69919863 T DE69919863 T DE 69919863T DE 69919863 T DE69919863 T DE 69919863T DE 69919863 D1 DE69919863 D1 DE 69919863D1
Authority
DE
Germany
Prior art keywords
gel
mixture
stable
aqueous
oily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69919863T
Other languages
English (en)
Other versions
DE69919863T8 (de
DE69919863T2 (de
Inventor
Jean-Marc Aiache
Pascale Gauthier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardana Bioscience Ltd
Original Assignee
Aiache Jean Marc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26234356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69919863(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9806958A external-priority patent/FR2779438B1/fr
Application filed by Aiache Jean Marc filed Critical Aiache Jean Marc
Publication of DE69919863D1 publication Critical patent/DE69919863D1/de
Application granted granted Critical
Publication of DE69919863T2 publication Critical patent/DE69919863T2/de
Publication of DE69919863T8 publication Critical patent/DE69919863T8/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/48—Thickener, Thickening system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69919863T 1998-06-03 1999-06-03 Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels Active DE69919863T8 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9806958A FR2779438B1 (fr) 1998-06-03 1998-06-03 Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
FR9806958 1998-06-03
US204089 1998-12-03
US09/204,089 US6187323B1 (en) 1998-06-03 1998-12-03 Stable gel mixture in the form of a mixture of oleogel and aqueous gel, process for its preparation, pharmaceutical and cosmetic compositions comprising it, and use of the pharmaceutical compositions
PCT/IB1999/001068 WO1999062497A1 (en) 1998-06-03 1999-06-03 Stable gel mixture in the form of a mixture of oleogel and aqueous gel

Publications (3)

Publication Number Publication Date
DE69919863D1 true DE69919863D1 (de) 2004-10-07
DE69919863T2 DE69919863T2 (de) 2005-09-01
DE69919863T8 DE69919863T8 (de) 2005-12-15

Family

ID=26234356

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919863T Active DE69919863T8 (de) 1998-06-03 1999-06-03 Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels

Country Status (6)

Country Link
EP (1) EP1083880B1 (de)
AT (1) ATE274900T1 (de)
AU (1) AU3951399A (de)
DE (1) DE69919863T8 (de)
ES (1) ES2228044T3 (de)
WO (1) WO1999062497A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
GB0524961D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents for systemic effect
MA29127B1 (fr) * 2006-06-30 2008-01-02 Yahya Bensouda Formulation d'une emulsion lipidique pour nutrition parenterale a base d'huile d'argane
GB2445539A (en) * 2006-12-29 2008-07-16 Ardana Bioscience Ltd Bigel composition
US20120183651A1 (en) * 2009-06-12 2012-07-19 Alejandro Gregorio Marangoni Chocolate compositions containing ethylcellulose
GB2485421B (en) 2010-11-15 2016-05-25 Mars Inc Dough products exhibiting reduced oil migration
SG189845A1 (en) 2010-12-01 2013-06-28 Omnis Biotechnology Inc Thixotropic compositions
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
MX365818B (es) 2011-11-23 2019-05-30 Therapeuticsmd Inc Formulaciones y terapias de reemplazo hormonal de combinacion naturales.
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2014052312A1 (en) 2012-09-28 2014-04-03 Mars, Incorporated Heat resistant chocolate
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
FR3002444B1 (fr) * 2013-02-25 2015-03-13 Oreal Composition cosmetique de type gel
FR3002449B1 (fr) * 2013-02-25 2015-04-03 Oreal Composition cosmetique de type gel
FR3002448B1 (fr) * 2013-02-25 2015-04-03 Oreal Composition cosmetique de type gel
FR3004343B1 (fr) 2013-04-12 2015-06-19 Oreal Composition cosmetique de type gel
US10206932B2 (en) 2014-05-22 2019-02-19 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
FR3021533B1 (fr) * 2014-05-28 2017-09-15 Oreal Composition cosmetique de type gel
CA2951284A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
FR3025098B1 (fr) 2014-08-28 2018-03-09 Oreal Composition cosmetique de type gel facilement demaquillable
FR3025100B1 (fr) 2014-08-28 2016-12-09 Oreal Composition cosmetique de type gel a tenue amelioree
FR3025096B1 (fr) 2014-08-28 2016-12-23 Oreal Composition gel/gel contenant un actif anti-transpirant
FR3025099B1 (fr) * 2014-08-28 2016-12-16 Oreal Composition cosmetique de type gel a tenue amelioree et non collante
ES2894864T3 (es) 2014-08-28 2022-02-16 Oreal Composición tipo gel/gel que comprende un filtro UV
FR3025097B1 (fr) 2014-08-28 2016-12-23 Oreal Gel/gel comprenant au moins deux charges a effet flouteur
FR3028753B1 (fr) * 2014-11-24 2018-01-05 L'oreal Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
FR3030261B1 (fr) 2014-12-18 2017-01-13 Oreal Composition comprenant des particules de polymere stabilise et un polymere filmogene hydrophobe
DE102015207621A1 (de) 2015-04-27 2016-10-27 Beiersdorf Ag Hautreinigungszubereitung
DE102015207624A1 (de) 2015-04-27 2016-10-27 Beiersdorf Ag Hautpflegezubereitung
EP3389603B1 (de) 2015-12-17 2020-07-15 L'Oréal Zusammensetzung vom gel/gel-typ auf basis von hydrophob beschichteten pigmenten und einer flüssigen fettsäure und/oder einer glykolverbindung
IL300437A (en) * 2016-01-07 2023-04-01 Viramal Ltd Gel preparations for administering a drug through the skin to maximize drug concentrations in the rough layer and serum and methods of using them
FR3067934B1 (fr) 2017-06-27 2019-08-09 L'oreal Composition gelifiee comprenant une dispersion d'agregats solides.
FR3067937B1 (fr) 2017-06-27 2019-12-20 L'oreal Composition gel-gel comprenant une cire a l'etat cristallin.
FR3075053B1 (fr) 2017-12-15 2020-07-10 L'oreal Composition de type gel/gel a base de pigments, d’au moins un dihydroxyalcane lineaire sature en c3-c8, d’acide salicylique sous forme libre
FR3076218B1 (fr) 2017-12-28 2019-12-27 L'oreal Composition gelifiee comprenant une microdispersion aqueuse de cire(s)
CN113164384A (zh) 2018-10-26 2021-07-23 维拉莫有限公司 黏膜粘附性凝胶组合物
ES2948955T3 (es) 2018-11-30 2023-09-22 Viramal Ltd Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante
FR3090327B1 (fr) 2018-12-20 2020-12-25 Oreal Composition gélifiée comprenant deux gélifiants hydrophiles et des agrégats solides
FR3090325B1 (fr) 2018-12-21 2021-01-01 Oreal Composition du type gel/gel comprenant des particules de nitrure de bore et au moins un pigment encapsule
DE102019119888A1 (de) * 2019-07-23 2021-01-28 Fachhochschule Bielefeld Neue Formulierung auf Basis eines Oleogels insbesondere zur Freisetzung von volatilen Komponenten und Verfahren zu dessen Herstellung
CN114144158A (zh) * 2019-07-24 2022-03-04 株式会社资生堂 含润肤剂的油包水乳剂及其使用方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
EP3922235A1 (de) 2020-06-11 2021-12-15 Viramal Limited Hydroalkoholisches gel und verfahren zu seiner herstellung
WO2023283652A1 (en) * 2021-07-08 2023-01-12 Minutri Inc. Gel compositions with high thermal stability and methods of making the same
CN114191381B (zh) * 2021-11-29 2023-10-24 华南农业大学 一种温敏型模拟塑性脂肪、口腔质构及消化行为可控的双凝胶及其制备和应用
CN115429703B (zh) * 2022-10-24 2023-09-22 中国热带农业科学院农产品加工研究所 双凝胶组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635463A1 (fr) * 1988-08-19 1990-02-23 Veprol Composition pharmaceutique comportant un principe actif peu soluble dans l'eau et au moins un glyceride gelifie par au moins un polymere cellulosique
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물

Also Published As

Publication number Publication date
EP1083880A1 (de) 2001-03-21
AU3951399A (en) 1999-12-20
DE69919863T8 (de) 2005-12-15
DE69919863T2 (de) 2005-09-01
ES2228044T3 (es) 2005-04-01
EP1083880B1 (de) 2004-09-01
ATE274900T1 (de) 2004-09-15
WO1999062497A1 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
DE69919863D1 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
ATE288744T1 (de) Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut
ES2151968T3 (es) Composiciones hemorroidales y metodo de utilizacion.
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
ATE269113T1 (de) Sprühfähige wundversorgungszusammensetzung
BR0107869A (pt) Composições farmacêuticas eletrogiradas
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
PT946143E (pt) Composicao gelificada a base de nitro-imidazole.
AU3694901A (en) A parasiticidal formulation and a method of making this formulation
ATE283045T1 (de) Stabile ascorbinsäure enthaltende zubereitung zur topischen anwendung
ES2176421T3 (es) Composicion topica gelificada estable que contiene un electrolito, un agente activo y etil hidroxietilcelulosa.
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
BR9809057A (pt) Composições antitussìgenas
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
MXPA01011941A (es) Humectante cosmetico no pegajoso para la piel y el cabello.
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
AU9446498A (en) Reducing agent with several constituents comprising at least a composition in powder form containing an agent for reducing hair sulphur bonds and method for permanent setting of keratin fibres
BR0104587A (pt) Composição estável
ES2137044T3 (es) Utilizacion de derivados de oxazolidinona como agentes antipenetrantes en una composicion cosmetica y/o dermatologica.
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
ES2102284T5 (es) Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion.
BR0009194A (pt) Composição do resorcinol

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: ARDANA BIOSCIENCE LTD., EDINBURGH, GB

8328 Change in the person/name/address of the agent

Representative=s name: REHBERG UND KOLLEGEN, 37073 GOETTINGEN

8365 Fully valid after opposition proceedings
R082 Change of representative

Ref document number: 1083880

Country of ref document: EP

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC